Electrophysiological changes in heart failure and their implications for arrhythmogenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2432-2441

  Coronel, R ^a   Wilders, Ronald ^a   Verkerk, Arie O ^a   Wiegerinck, Rob F ^b   Benoist, David ^c   Bernus, Olivier ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Arrhythmia mechanism; Diet; Heart failure; Intercellular coupling; Pulmonary hypertension; Stretch

Indexed keywords

CALCIUM; CONNEXIN 43; GAP JUNCTION PROTEIN; POTASSIUM CHANNEL; SODIUM CHANNEL;

ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CATHETER ABLATION; DIET; ECHOCARDIOGRAPHY; ENERGY METABOLISM; EXTRACELLULAR MATRIX; EXTRASYSTOLE; FATTY ACID OXIDATION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE WALL; HUMAN; MEMBRANE DEPOLARIZATION; NERVE BLOCK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QT DISPERSION; QT PROLONGATION; REVIEW; SODIUM CHANNELOPATHY; SODIUM CURRENT; SUDDEN CARDIAC DEATH; SUDDEN DEATH; T WAVE;

EID: 84887608039     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.04.002     Document Type: Review

References (101)

1. Tomaselli G.F., Zipes D.P. What causes sudden death in heart failure?. Circ. Res. 2004, 95:754-763.
2. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine 1997, W. B. Saunders, Philadelphia.
3. Coronel R., van Lieshout J.J., de Groot J.R. Defining heart failure. Cardiovasc. Res. 2001, 50-3:419-422.
4. Connolly S.J., Dorian P., Roberts R.S., Gent M., Bailin S., Fain E.S., Thorpe K., Champagne J., Talajic M., Coutu B., Gronefeld G.C., Hohnloser S.H. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 2006, 295:165-171.
5. Nakahara S., Tung R., Ramirez R.J., Michowitz Y., Vaseghi M., Buch E., Gima J., Wiener I., Mahajan A., Boyle N.G., Shivkumar K. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J. Am. Coll. Cardiol. 2010, 55:2355-2365.
6. Janse M.J., Van Capelle F.J.L., Morsink H., Kléber A.G., Wilms-Schopman F., Cardinal R., Naumann d'Alnoncourt C., Durrer D. Flow of "injury" current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Evidence for two different arrhythmogenic mechanisms. Circ. Res. 1980, 47:151-165.
7. Pogwizd S.M. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation 1995, 92:1034-1048.
8. Vermeulen J.T., McGuire M.A., Opthof T., Coronel R., De Bakker J.M.T., Kloepping C., Janse M.J. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc. Res. 1994, 28:1547-1554.
9. Issa Z.F., Rosenberger J., Groh W.J., Miller J.M., Zipes D.P. Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events. Hear. Rhythm. 2005, 2:979-983.
10. van Oort R.J., Garbino A., Wang W., Dixit S.S., Landstrom A.P., Gaur N., De Almeida A.C., Skapura D.G., Rudy Y., Burns A.R., Ackerman M.J., Wehrens X.H.T. Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice/clinical perspective. Circulation 2011, 123:979-988.
11. van der Bom T., Bouma B.J., Meijboom F.J., Zwinderman A.H., Mulder B.J.M. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am. Heart J. 2012, 164:568-575.
12. 2+ currents in compensated hypertrophy and heart failure. Cardiovasc. Res. 1998, 37:300-311.
13. Aiba T., Tomaselli G. Electrical remodeling in dyssynchrony and resynchronization. J. Cardiovasc. Trans. Res. 2012, 5:170-179.
14. Janse M.J., Vermeulen J.T., Opthof T., Coronel R., Wilms-Schopman F.J.G., Rademaker H.M.E., Baartscheer A., Dekker L.R.C. Arrhythmogenesis in heart failure. J. Cardiovasc. Electrophysiol. 2001, 12:496-499.
15. Roden D.M. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin. Electrophysiol. 1998, 21:1029-1034.
16. Franz M.R., Cima R., Wang D., Profitt D., Kurz R. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 1992, 86:968-978.
17. Kinoshita O., Tomita T., Hanaoka T., Tsutsui H., Imamura H., Yazaki Y., Watanabe N., Hongo M., Kubo K. T-wave alternans in patients with right ventricular tachycardia. Cardiology 2003, 100:86-92.
18. Janse M.J., Kléber A.G., Downar E., Durrer D. Changements electrophysiologiques pendant l'ischemie myocardique et mecanisme possible des troubles du rythme ventriculaire. Ann. Cardiol. Angeiol. 1977, 26:551-554.
19. Jackson C.E., Myles R.C., Tsorlalis I.K., Dalzell J.R., Spooner R.J., Rodgers J.R., Bezlyak V., Greenlaw N., Ford I., Cobbe S.M., Petrie M.C., McMurray J.J.V. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. Eur. J. Hear. Fail. 2012, 14:377-386.
20. Michael G., Xiao L., Qi X.Y., Dobrev D., Nattel S. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc. Res. 2009, 81:491-499.
21. Nattel S., Maguy A., Le Bouter S., Yeh Y.H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev. 2007, 87:425-456.
22. + currents in myocytes from epicardial border zone of the infarcted heart: a possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ. Res. 1997, 81:110-119.
23. Pogwizd S.M., Hoyt R.H., Saffitz J.E., Corr P.B., Cox J.L., Cain M.E. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992, 86:1872-1887.
24. Pinsky D.J., Sciacca E.S., Steinberg J.S. QT dispersion as a marker of risk in patients awaiting heart transplantation. J. Am. Coll. Cardiol. 1997, 29:1576-1584.
25. Mines G.R. On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. Trans. R. Soc. Can. Sect. 1914, IV:43-53.
26. Han J., Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ. Res. 1964, 14:44-61.
27. Coronel R., Wilms-Schopman F.J.G., Opthof T., Janse M.J. Dispersion of repolarization and arrhythmogenesis. Hear. Rhythm. 2009, 6:537-543.
28. + channel blockade depend on the site of application relative to gradients in repolarization. Front. Card. Electrophysiol. 2011, 1:10.
29. Wiegerinck R.F., van Veen A.A., Belterman C.N., Schumacher C.A., Noorman M., de Bakker J.M., Coronel R. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Hear. Rhythm. 2008, 5:1178-1185.
30. Ai X., Pogwizd S.M. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ. Res. 2005, 96:54-63.
31. Severs N.J., Bruce A.F., Dupont E., Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc. Res. 2008, 80:9-19.
32. Jansen J.A., Noorman M., Musa H., Stein M., de Jong S., van der Nagel R., Hund T.J., Mohler P.J., Vos M.A., van Veen T.A., de Bakker J.M., Delmar M., van Rijen H.V. Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice. Hear. Rhythm. 2012, 9:600-607.
33. Stein M., van Veen T.A.B., Hauer R.N.W., de Bakker J.M.T., van Rijen H.V.M. A 50% reduction of excitability but not of intercellular coupling affects conduction velocity restitution and activation delay in the mouse heart. PLoS One 2011, 6:e20310.
34. Jongsma H.J., Wilders R. Gap junctions in cardiovascular disease. Circ. Res. 2000, 86:1193-1197.
35. Wilders R. Arrhythmogenic right ventricular cardiomyopathy: considerations from in silico experiments. Front. Physiol. 2012, 3:168.
36. Wiegerinck R.F., Verkerk A.O., Belterman C.N., Van Veen T.A.B., Baartscheer A., Opthof T., Wilders R., de Bakker J.M.T., Coronel R. Larger cell size in rabbits with heart failure increases myocardial conduction velocity and QRS duration. Circulation 2006, 113:806-813.
37. Shiroshita-Takeshita A., Sakabe M., Haugan K., Hennan J.K., Nattel S. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007, 115:310-318.
38. Wiegerinck R.F., De Bakker J.M.T., Opthof T., de Jonge N., Kirkels H., Wilms-Schopman F.J.G., Coronel R. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure. Basic Res. Cardiol. 2009, 104:321-332.
39. Delmar M. Connexin43 regulates sodium current; ankyrin-G modulates gap junctions: the intercalated disc exchanger. Cardiovasc. Res. 2012, 93:220-222.
40. den Ruijter H.M., Verkerk A.O., Schumacher C.A., Houten S.M., Belterman C.N.W., Baartscheer A., Brouwer I.A., van Bilsen M., de Roos B., Coronel R. A diet rich in unsaturated fatty acids prevents progression toward heart failure in a rabbit model of pressure and volume overload/clinical perspective. Circ. Heart Fail. 2012, 5:376-384.
41. Gima K., Rudy Y. Ionic current basis of electrocardiographic waveforms: a model study. Circ. Res. 2002, 90:889-896.
42. Baartscheer A., Schumacher C.A., Belterman C.N.W., Coronel R., Fiolet J.W.T. SR calcium handling and calcium after-transients in a rabbit model of heart failure. Cardiovasc. Res. 2003, 58:99-108.
43. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008, 70:23-49.
44. Gomez A.M., Valdivia H.H., Cheng H., Lederer M.R., Santana L.F., Cannell M.B., McCune S.A., Altschuld R.A., Lederer W.J. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997, 276:800-806.
45. Griffiths E.J., Balaska D., Cheng W.H.Y. The ups and downs of mitochondrial calcium signalling in the heart. Biochim. Biophys. Acta Bioenerg. 2010, 1797:856-864.
46. Weber K.T., Brilla C.G., Campbell S.E., Guarda E., Zhou G., Sriram K. Myocardial fibrosis: role of angiotensin II and aldosterone. [Review] [74 refs]. Basic Res. Cardiol. 1993, 88(Suppl. 1):107-124.
47. Weber K.T., Brilla C.G., Janicki J.S. Myocardial fibrosis: functional significance and regulatory factors. [Review] [116 refs]. Cardiovasc. Res. 1993, 27:341-348.
48. Boulaksil M., Winckels S.K.G., Engelen M.A., Stein M., van Veen T.A.B., Jansen J.A., Linnenbank A.C., Bierhuizen M.F.A., Groenewegen W.A., van Oosterhout M.F.M., Kirkels J.H., de Jonge N., Varr A., Vos M.A., de Bakker J.M.T., van Rijen H.V.M. Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur. J. Hear. Fail. 2010, 12:913-921.
49. Wilders R., Wagner M.B., Golod D., Kumar R., Wang Y.-G., Goolsby W.N., Joyner R.W., Jongsma H.J. Effects of anisotropy on the development of cardiac arrhythmias associated with focal activity. Pfluegers Arch. 2000, 441:301-312.
50. Hoogendijk M.G., Potse M., Vinet A., de Bakker J.M., Coronel R. ST segment elevation by current-to-load mismatch: an experimental and computational study. Hear. Rhythm. 2011, 8:111-118.
51. Hoogendijk M.G., Opthof T., Postema P.G., Wilde A.A., de Bakker J.M., Coronel R. The Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ. Arrhythm. Electrophysiol. 2010, 3:283-290.
52. Spach M.S., Miller W.T., Geselowitz D.B., Barr R.C., Kootsey J.M., Johnson E.A. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ. Res. 1981, 48:39-54.
53. de Bakker J.M., van Capelle F.J., Janse M.J., Tasseron S., Vermeulen J.T., de Jonge N., Lahpor J.R. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 1993, 88:915-926.
54. Saumarez R.C., Slade A.K.B., Grace A.A., Sadoul N., Camm A.J., Mckenna W.J. The significance of paced electrgram fractionation in hypertrophic cardiomyopathy. Circulation 1995, 91:2762-2768.
55. Kawara T., Derksen R., de Groot J.R., Coronel R., Tasseron S., Linnenbank A.C., Hauer R.N.W., Kirkels H., Janse M.J., De Bakker J.M.T. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 2001, 104:3069-3075.
56. Davidenko J.M., Pertsov A.V., Salomonsz R., Baxter W., Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 1992, 355:349-351.
57. Samie F.H., Jalife J. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart. Cardiovasc. Res. 2001, 50:242-250.
58. Coumel P. The management of clinical arrhythmias. An overview on invasive versus non-invasive electrophysiology. Eur. Heart J. 1987, 8:92-99.
59. Tracy C.M., Winkler J., Brittain E., Leon M.B., Epstein S.E., Bonow R.O. Determinants of ventricular arrhythmias in mildly symptomatic patients with coronary artery disease and influence of inducible left ventricular dysfunction on arrhythmia frequency. JACC 1978, 9:483-488.
60. Hansen D.E., Craig C.S., Hondeghem L.M. Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback. Circulation 1990, 81:1094-1105.
61. Wang Z., Taylor K., Denney W.D., Hansen D.E. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation 1994, 90:2022-2031.
62. Kamkin A., Kiseleva I., Isenberg G. Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy. Cardiovasc. Res. 2000, 48:402-408.
63. Opthof T., Sutton P., Coronel R., Wright S., Kallis P., Taggart P. The association of abnormal ventricular wall motion and increased dispersion of repolarization in humans is independent of the presence of myocardial infarction. Front. Physiol. 2012, 3.
64. Marchioli R., Schweiger C., Tavazzi L., Valagussa F. Efficacy of n-polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Lipids 2001, 36:S119-S126.
65. Den Ruijter H.M., Berecki G., Opthof T., Verkerk A.O., Zock P.L., Coronel R. Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc. Res. 2007, 73:316-325.
66. Billman G.E., Kang J.X., Leaf A. Prevention of sudden death by dietary pure n-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452-2457.
67. Verkerk A.O., van Ginneken A.C.G., Berecki G., den Ruijter H.M., Schumacher C.A., Veldkamp M.W., Baartscheer A., Casini S., Opthof T., Hovenier R., Fiolet J.W.T., Zock P.L., Coronel R. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc. Res. 2006, 70:509-520.
68. den Ruijter H.M., Berecki G., Verkerk A.O., Bakker D., Baartscheer A., Schumacher C.A., Belterman C.N.W., de Jonge N., Fiolet J.W.T., Brouwer I.A., Coronel R. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 2008, 117:536-544.
69. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chugh S., McClelland J., Cook J., MacMurdy K., Swenson R., Connor S.L., Gerhard G., Kraemer D.F., Oscran D., Marchant C., Calhoun D., Shriner R., McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. JAMA 2005, 293:2884-2891.
70. Coronel R., Wilms-Schopman F.J., Den Ruijter H.M., Belterman C.N., Schumacher C.A., Opthof T., Hovenier R., Lemmens A.G., Terpstra A.H., Katan M.B., Zock P. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc. Res. 2006, 73:386-394.
71. Chen Q., Cheng L.-Q., Xiao T.-H., Zhang Y.-X., Zhu M., Zhang R., Li K., Wang Y., Li Y. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc. Drugs Ther. 2011, 25:259-265.
72. Lou Q., Janks D.L., Holzem K.M., Lang D., Onal B., Ambrosi C.M., Fedorov V.V., Wang I.W., Efimov I.R. Right ventricular arrhythmogenesis in failing human heart: the role of conduction and repolarization remodeling. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H1426-H1434.
73. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., Priori S.G., Quinones M.A., Roden D.M., Silka M.J., Tracy C., Smith S.C., Jacobs A.K., Adams C.D., Antman E.M., Anderson J.L., Hunt S.A., Halperin J.L., Nishimura R., Ornato J.P., Page R.L., Riegel B., Blanc J.J., Budaj A., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., Zamorano J.L. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e385-e484.
74. Lambert V., Capderou A., Le B.E., Rucker-Martin C., Deroubaix E., Gouadon E., Raymond N., Stos B., Serraf A., Renaud J.F. Right ventricular failure secondary to chronic overload in congenital heart disease: an experimental model for therapeutic innovation. J. Thorac. Cardiovasc. Surg. 2010, 139:1197-1204.
75. Lee J.K., Kodama I., Honjo H., Anno T., Kamiya K., Toyama J. Stage-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy. Am. J. Physiol. 1997, 272:H2833-H2842.
76. Benoist D., Stones R., Drinkhill M., Bernus O., White E. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H2230-H2237.
77. Turrini P., Corrado D., Basso C., Nava A., Bauce B., Thiene G. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 2001, 103:3075-3080.
78. Helbing W.A., Roest A.A., Niezen R.A., Vliegen H.W., Hazekamp M.G., Ottenkamp J., de R.A., Van der Wall E.E. ECG predictors of ventricular arrhythmias and biventricular size and wall mass in tetralogy of Fallot with pulmonary regurgitation. Heart 2002, 88:515-519.
79. Hong-Liang Z., Qin L., Zhi-Hong L., Zhi-hui Z., Chang-Ming X., Xin-Hai N., Jian-guo H., Ying-jie W., Shu Z. Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension. Wien. Klin. Wochenschr. 2009, 121:330-333.
80. Hardziyenka M., Campian M.E., Verkerk A.O., Surie S., van Ginneken A.C., Hakim S., Linnenbank A.C., de Bruin-Bon H.A., Beekman L., van der Plas M.N., Remme C.A., van Veen T.A., Bresser P., de Bakker J.M., Tan H.L. Electrophysiologic remodeling of the left ventricle in pressure overload-induced right ventricular failure. J. Am. Coll. Cardiol. 2012, 59:2193-2202.
81. Umar S., Lee J.H., de L.E., Iorga A., Partow-Navid R., Bapat A., van der Laarse A., Saggar R., Saggar R., Ypey D.L., Karagueuzian H.S., Eghbali M. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension. Circ. Arrhythm. Electrophysiol. 2012, 5:181-190.
82. Benoist D., Stones R., Drinkhill M.J., Benson A.P., Yang Z., Cassan C., Gilbert S.H., Saint D.A., Cazorla O., Steele D.S., Bernus O., White E. Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H2381-H2395.
83. Uzzaman M., Honjo H., Takagishi Y., Emdad L., Magee A.I., Severs N.J., Kodama I. Remodeling of gap junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 2000, 86:871-878.
84. Kaplan S.R., Gard J.J., Protonotarios N., Tsatsopoulou A., Spiliopoulou C., Anastasakis A., Squarcioni C.P., Mckenna W.J., Thiene G., Basso C., Brousse N., Fontaine G., Saffitz J.E. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Hear. Rhythm. 2004, 1:3-11.
85. Cerrone M., Noorman M., Lin X., Chkourko H., Liang F.X., van der Nagel R., Hund T., Birchmeier W., Mohler P., van Veen T.A., van Rijen H.V., Delmar M. Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. Cardiovasc. Res. 2012, 95:460-468.
86. Lourenco A.P., Roncon-Albuquerque R., Bras-Silva C., Faria B., Wieland J., Henriques-Coelho T., Correia-Pinto J., Leite-Moreira A.F. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1587-H1594.
87. Marra M.P., Leoni L., Bauce B., Corbetti F., Zorzi A., Migliore F., Silvano M., Rigato I., Tona F., Tarantini G., Cacciavillani L., Basso C., Buja G., Thiene G., Iliceto S., Corrado D. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ. Arrhythm. Electrophysiol. 2012, 5:91-100.
88. Zeppenfeld K., Schalij M.J., Bartelings M.M., Tedrow U.B., Koplan B.A., Soejima K., Stevenson W.G. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007, 116:2241-2252.
89. Vogel M., Sponring J., Cullen S., Deanfield J.E., Redington A.N. Regional wall motion and abnormalities of electrical depolarization and repolarization in patients after surgical repair of tetralogy of Fallot. Circulation 2001, 103:1669-1673.
90. Steriotis A.K., Bauce B., Daliento L., Rigato I., Mazzotti E., Folino A.F., Marra M.P., Brugnaro L., Nava A. Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy. Am. J. Cardiol. 2009, 103:1302-1308.
91. Thambo J.B., De G.M., Xhaet O., Santos P.D., Roubertie F., Labrousse L., Iriart X., Ploux S., Haissaguerre M., Bordachar P. Biventricular pacing in patients with Tetralogy of Fallot: non-invasive epicardial mapping and clinical impact. Int. J. Cardiol. 2013 Feb 20, 163(2):170-174. Epub 2011 Jul 31. 10.1016/j.ijcard.2011.06.005.
92. Tops L.F., Prakasa K., Tandri H., Dalal D., Jain R., Dimaano V.L., Dombroski D., James C., Tichnell C., Daly A., Marcus F., Schalij M.J., Bax J.J., Bluemke D., Calkins H., Abraham T.P. Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 2009, 54:445-451.
93. Shanmugam N., Yap J., Tan R.S., Le T.T., Gao F., Chan J.X., Chong D., Ho K.L., Tan B.Y., Ching C.K., Teo W.S., Tan J.L., Liew R. Fragmented QRS complexes predict right ventricular dysfunction and outflow tract aneurysms in patients with repaired tetralogy of Fallot. Int. J. Cardiol. 2012 Apr 20, Epub ahead of print.
94. Peters S., Truemmel M., Koehler B. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. J. Cardiovasc. Med. (Hagerstown) 2012, 13:295-298.
95. Cheung M.M., Weintraub R.G., Cohen R.J., Karl T.R., Wilkinson J.L., Davis A.M. T wave alternans threshold late after repair of tetralogy of Fallot. J. Cardiovasc. Electrophysiol. 2002, 13:657-661.
96. Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C., Thiene G., Danieli G.A., Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 2001, 10:189-194.
97. Gray R., Greve G., Chen R., Fry C., Barron D., Lab M.J., White P.A., Redington A.N., Penny D.J. Right ventricular myocardial responses to chronic pulmonary regurgitation in lambs: disturbances of activation and conduction. Pediatr. Res. 2003, 54:529-535.
98. White E. Mechanosensitive channels: therapeutic targets in the myocardium?. Curr. Pharm. Des. 2006, 12:3645-3663.
99. Gatzoulis M.A., Till J.A., Somerville J., Redington A.N. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995, 92:231-237.
100. Sarvari S.I., Haugaa K.H., Anfinsen O.G., Leren T.P., Smiseth O.A., Kongsgaard E., Amlie J.P., Edvardsen T. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur. Heart J. 2011, 32:1089-1096.
101. Verkerk A.O., Baartscheer A., de Groot J.R., Wilders R., Coronel R. Etiology-dependency of ionic remodeling in cardiomyopathic rabbits. Int. J. Cardiol. 2011, 148:154-160.